Impact of Anesthesia Method on Immune Response in Patients Undergoing Radical Surgery for Breast Cancer (a Meta-Analysis of Comparative Clinical Studies)
-
Published:2022-08-25
Issue:4
Volume:18
Page:20-28
-
ISSN:2411-7110
-
Container-title:General Reanimatology
-
language:
-
Short-container-title:Obŝaâ reanimatologiâ
Author:
Likhvantsev V. V.1, Landoni G.2, Subbotin V. V.3, Kadantseva K. K.4, Zhukova L. A.5, Yadgarov M. Ya.3, Beletti A.6, Novikov A. A.5, Berikashvili L. B.3, Kuzovlev A. N.3
Affiliation:
1. V. A. Negovsky Research Institute of General Reanimatology,
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology; I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia 2. Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University 3. V. A. Negovsky Research Institute of General Reanimatology,
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology 4. V. A. Negovsky Research Institute of General Reanimatology,
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology; A. S. Loginov Moscow Clinical Research Center, Moscow Department of Health 5. A. S. Loginov Moscow Clinical Research Center, Moscow Department of Health 6. Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute
Abstract
Introduction and aim. Recent evidence suggests that inhalation anesthesia (IA) is associated with higher cancer mortality than total intravenous anesthesia (TIVA), possibly due to a modulation of the immune response.The aim of this study was to determine the impact of anesthesia techniques on selected parameters of patient immunity considering the evidence of relationship between the anesthesia methods and immune status and, consequently, the incidence of cancer recurrence.Methods. We performed a meta-analysis of clinical studies published in PubMed, Google Scholar, and Cochrane databases, aimed at assessing the impact of anesthesia on the postoperative immune status of patients undergoing breast cancer (BC) surgery. Five randomized and three observational studies were included (a total of 637 patients, of which 320 (50.2%) in the TIVA group). Data on leukocyte counts, matrix metalloproteinases (MMP) 9 and 3, interleukins (IL) 6 and 10 levels, and neutrophil-lymphocyte index (NLI) values were retrieved.Results. Patients after breast cancer surgery who underwent TIVA had significantly lower white blood cell counts (standardized mean difference (SMD)=–0.32; 95% CI: –0.58 to –0.06; I2=58%, P=0.020) and MMP-9 (SMD=–0.35; 95% CI: –0.67 to –0.03; P=0.030; I2=0%) in the postoperative period compared with patients receiving IA. No significant differences in the levels of MMP-3, IL-6, IL-10, and NLI values were found between the two groups.Conclusion. The patients who underwent breast cancer surgery under TIVA had lower blood leukocyte counts and levels of MMP-9, which is involved in the remodeling of extracellular matrix, compared with those operated on under IA, suggesting that the anesthesia method may have an impact on the immunity of breast cancer patients.
Publisher
FSBI SRIGR RAMS
Subject
Critical Care and Intensive Care Medicine
Reference39 articles.
1. Tsimberidou A.M., Fountzilas E., Nikanjam M., Kurzrock R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020; 86: 102019. DOI: 10.1016/j.ctrv.2020.102019. PMID: 32251926. 2. Zaimy M.A., Saffarzadeh N., Mohammadi A., Pourghadamyari H., Izadi P., Sarli A., Moghaddam LK., Paschepari SR., Azizi H., Torkamandi S., Tavakkoly-Bazzaz J. New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther. 2017; 24 (6): 233–243. DOI: 10.1038/cgt.2017.16. PMID: 28574057. 3. Sullivan R., Alatise O.I., Anderson B.O., Audisio R., Autier P., Aggarwal A., Balch C., Brennan M.F., Dare A., D'Cruz A., Eggermont A.M., Fleming K., Gueye S.M., Hagander L., Herrera C.A., Holmer H., Ilbawi A.M., Jarnheimer A., Ji J.F., Kingham T.P., Liberman J., Leather A.J.M., Meara J.G., Mukhopadhyay S., Murthy S.S., Omar S., Parham G.P., Pramesh C.S., Riviello R., Rodin D., Santini L., Shrikhande S.V., Shrime M., Thomas R., Tsunoda A.T., van de Velde C., Veronesi U., Vijaykumar D.K., Watters D., Wang S., Wu Y-L., Zeiton M., Purushotham A. Global cancer surgery: delivering safe., affordable., and timely cancer surgery. Lancet Oncol. 2015; 16 (11): 1193–1224. DOI: 10.1016/S1470-2045(15)00223-5. PMID: 26427363. 4. Soltanizadeh S., Degett T.H., Gögenur I. Outcomes of cancer surgery after inhalational and intravenous anesthesia: a systematic review. J Clin Anesth. 2017; 42: 19–25. DOI: 10.1016/j.jclinane.2017.08.001. PMID: 28797751. 5. Snyder G.L., Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth. 2010; 105 (2): 106–115. DOI: 10.1093/bja/aeq164. PMID: 20627881.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|